Modern Rheumatology · 2011 · 40 citations · 8 references
MedicineInternal MedicinePharmacotherapyAutoimmunityHepatologyImmunotherapyAutoimmune DiseasesAutoimmune Liver Disease TreatmentChronic Liver DiseaseLiver DiseaseViral HepatitisViral Hepatitis TreatmentAmyloidosis Of The LiverChronic Viral HepatitisHepatitis B TherapyHepatitis B Virus ManagementHepatitis B Virus Persistence
We report successful tocilizumab (TCZ) use in a patient with adult-onset Still’s disease (AOSD) complicated by chronic hepatitis B (CHB) and AA amyloidosis (AAA). Treatments with corticosteroid and various types of immunosuppressants were unsuccessful. Aggravation of CHB ensued, and entecavir was started. Normalisation of liver function and hepatitis B virus (HBV) DNA were confirmed. TCZ was then started. His arthritis and AAA improved dramatically. TCZ is an excellent treatment for refractory AOSD and is feasible in an HBV-infected patient.
8
Shumpei Yokota, Tomoyuki Imagawa, Masaaki Mori et al. · The Lancet · 2008 · 797 citations
E. G. L. Bywaters · Annals of the Rheumatic Diseases · 1971 · 764 citations · Full text
JJ Cush, Herbert Dc, Cooperstein La · Arthritis & Rheumatism · 1987 · 311 citations